Nektar Therapeutics
NKTR
$75.06
$2.853.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.71% | 10.52% | -35.15% | -24.41% | -15.94% |
| Total Receivables | 10.57% | -39.28% | -53.40% | -68.45% | -28.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -12.55% | -17.19% | -27.03% | -46.92% | -43.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 749.51% | -79.74% | 79.85% | 54.37% | -54.98% |
| Total Current Assets | 1.90% | -1.79% | -36.80% | -28.12% | -20.99% |
|
|
|||||
| Total Current Assets | 1.90% | -1.79% | -36.80% | -28.12% | -20.99% |
| Net Property, Plant & Equipment | -57.70% | -19.57% | -56.72% | -67.87% | -67.92% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.54% | 14.10% | 16.46% | 15.79% | 0.06% |
| Total Assets | -7.72% | -2.15% | -39.55% | -35.29% | -23.66% |
|
|
|||||
| Total Accounts Payable | -6.83% | 81.45% | 120.56% | 103.65% | 17.38% |
| Total Accrued Expenses | -27.81% | -12.94% | 21.67% | 42.66% | 42.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.16% | 3.16% | 3.16% | 12.77% | 3.16% |
| Total Finance Division Other Current Liabilities | -4.88% | -61.95% | -2.44% | -35.10% | -8.38% |
| Total Other Current Liabilities | -4.88% | -61.95% | -2.44% | -35.10% | -8.38% |
| Total Current Liabilities | -12.81% | -1.84% | 24.54% | 35.35% | 19.76% |
|
|
|||||
| Total Current Liabilities | -12.81% | -1.84% | 24.54% | 35.35% | 19.76% |
| Long-Term Debt | -31.18% | -23.17% | -25.05% | -26.76% | -18.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.09% | -19.62% | -18.31% | -17.12% | -16.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.11% | -27.30% | -30.00% | 55.88% | 56.22% |
| Total Liabilities | -21.61% | -16.53% | -12.10% | -9.95% | -8.96% |
|
|
|||||
| Common Stock & APIC | 5.20% | 4.22% | 0.49% | 0.54% | 1.43% |
| Retained Earnings | -4.56% | -3.35% | -3.43% | -3.79% | -3.42% |
| Treasury Stock & Other | 100.58% | 102.12% | 13.74% | 12.99% | -3,773.75% |
| Total Common Equity | 47.90% | 74.06% | -130.38% | -89.16% | -53.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.90% | 74.06% | -130.38% | -89.16% | -53.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.90% | 74.06% | -130.38% | -89.16% | -53.63% |
|
|
|||||